跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,793 条关于
“Aβ42/40 ratio”
全部
8,793
临床试验
2,820
药物
354
机构
148
资讯
5,471
3年前
Lecanemab PK/PD Analysis Shows Effective Amyloid Reduction in Early Alzheimer's
3年前
Lecanemab Demonstrates Sustained Clinical Benefit in Early Alzheimer's Disease
3个月前
Sysmex Launches HISCL™ Platform for Rapid, Scalable Alzheimer's Blood Testing with 17-Minute Results
2年前
Blarcamesine Shows Promise in Slowing Alzheimer's Decline in Phase IIb/III Trial
去年
Lecanemab Shows Long-Term Benefits in Early Alzheimer's, Eisai Presents New Data
去年
Early Lecanemab Treatment Shows Sustained Benefits in Alzheimer's Disease
去年
Lecanemab Shows Sustained Cognitive Benefits in Early Alzheimer's with Long-Term Treatment
去年
Alzheimer's Prevention Trials Update: Lecanemab, Donanemab, and Remternetug
去年
Lecanemab Shows Long-Term Benefits in Early Alzheimer's Disease, Eisai Data Shows
去年
Cognivue Clarity Effectively Identifies MCI and Alzheimer's Disease, Study Shows
第 1 页,共 548 页
上一页
下一页